General Info

Subject Matter Expert in developing US strategies for drugs, and biologics; Regulatory Affairs experience in Emerging Markets; Experienced management and leadership in organizing, authoring, and review of IND, NDA, BLA original applications, amendments, supplements, Orphan Drug Designation, Lifecycle maintenance, label development and advertising and promotion. Supported pharmaceutical companies at all phases of development and lifecycle management.